Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients. 1993

G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
Drug Development Section, Institute of Cancer Research, Sutton, Surrey, UK.

This study describes the application of LC/MS/MS to the determination of phase I and phase II metabolites of tamoxifen in urine and plasma samples of breast cancer patients. In the plasma extracts, in addition to the parent drug and N-desmethyltamoxifen, a minor metabolite tamoxifen N-oxide was identified for the first time in human. Four intact glucuronides of tamoxifen metabolites were isolated in the 24-hr posttreatment urine sample. They were the glucuronides of 4-hydroxytamoxifen, 4-hydroxy-N-desmethyltamoxifen, dihydroxytamoxifen, and a monohydroxy-N-desmethyltamoxifen. Hydroxylation followed by glucuronidation is a well-established metabolic route of tamoxifen, and this study describes for the first time direct analyses of these metabolites in human urine samples using on-line LC tandem MS.

UI MeSH Term Description Entries
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013629 Tamoxifen One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. ICI-46,474,ICI-46474,ICI-47699,Nolvadex,Novaldex,Soltamox,Tamoxifen Citrate,Tomaxithen,Zitazonium,Citrate, Tamoxifen,ICI 46,474,ICI 46474,ICI 47699,ICI46,474,ICI46474,ICI47699

Related Publications

G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
March 1998, Clinical cancer research : an official journal of the American Association for Cancer Research,
G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
October 1976, Cancer treatment reports,
G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
January 1990, Journal of cancer research and clinical oncology,
G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
February 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
May 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
January 1986, The Journal of international medical research,
G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
December 2019, BMC pharmacology & toxicology,
G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
February 2010, Clinical cancer research : an official journal of the American Association for Cancer Research,
G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
January 1990, European journal of cancer (Oxford, England : 1990),
G K Poon, and Y C Chui, and R McCague, and P E Lłnning, and R Feng, and M G Rowlands, and M Jarman
January 2001, Anticancer research,
Copied contents to your clipboard!